Get PT-141 (Bremelanotide) Online in New York | OmniRx Health
Sexual Wellness Treatment in New York
PT-141 (Bremelanotide) is a melanocortin receptor agonist that enhances sexual desire and arousal through the central nervous system — not the vascular system. It is the first non-hormonal treatment for hypoactive sexual desire disorder approved by the FDA.
Key Benefits
- Works through the brain to enhance desire and arousal
- Effective for both men and women
- Addresses root causes of low libido rather than just physical response
- FDA-approved active ingredient (Vyleesi for women)
- Unique central mechanism distinct from PDE5 inhibitors
Who is a Good Candidate?
Men and women experiencing low sexual desire (HSDD), reduced libido, or sexual arousal difficulties who want a centrally-acting treatment that addresses desire rather than just the physical mechanics of sexual function.
Starting from $199/month
Serving New York
New York is a world unto itself—from the skyscrapers of Manhattan to the farms of the Finger Lakes, the tech corridors of the Hudson Valley to the winter sports meccas of the Adirondacks. OmniRx Health serves every New Yorker. Whether you're a Wall Street professional who can't take time off, an upstate family far from specialists, or an artist in Brooklyn seeking convenient care, our telehealth platform delivers Empire State-quality medicine to wherever you are.
OmniRx Health providers are licensed by the New York State Education Department to deliver telehealth across the Empire State.
New York's vast pharmacy network from NYC to Buffalo ensures prescription access, with specialized compounding pharmacies available throughout.
New York has comprehensive telehealth laws that support virtual care delivery across the state's diverse urban and rural communities.
New York mandates telehealth coverage, including requirements for commercial insurers and Medicaid to cover virtual visits.
Frequently Asked Questions
- How does PT-141 work differently from Viagra or Cialis?
- PDE5 inhibitors like sildenafil and tadalafil work by increasing blood flow to the genitals — they improve physical erectile function but do not enhance sexual desire. PT-141 activates melanocortin receptors in the brain that regulate sexual motivation and arousal, addressing the psychological and neurological dimension of sexual response that PDE5 inhibitors do not target.
- Can women use PT-141?
- Yes. PT-141 was originally developed in part to address hypoactive sexual desire disorder (HSDD) in women. Vyleesi (bremelanotide injection) is FDA-approved for premenopausal women with HSDD. It has also demonstrated benefits in men with situational erectile dysfunction related to low desire or performance anxiety.
- How and when is PT-141 administered?
- PT-141 is administered as a subcutaneous injection, typically 45 minutes to 2 hours before anticipated sexual activity to allow sufficient time for central nervous system activation. The injection site is typically the abdomen. Nausea is the most commonly reported side effect and is usually mild and temporary.
- Is telehealth legal in New York?
- Yes, New York has comprehensive telehealth laws supporting virtual healthcare. The state expanded virtual care access permanently, ensuring residents can access quality telehealth services.
- Can NYC residents use telehealth despite nearby doctors?
- Absolutely. Telehealth saves busy New Yorkers time by eliminating travel and waiting rooms. Get the same quality care from your apartment, office, or wherever you are.
- Does NY Medicaid cover telehealth?
- Yes, New York Medicaid covers telehealth services for eligible members. The state has made permanent many telehealth flexibilities that improve access to care.